ES2194588B1 - Precursores opticamente puros de paroxetina. - Google Patents

Precursores opticamente puros de paroxetina.

Info

Publication number
ES2194588B1
ES2194588B1 ES200101648A ES200101648A ES2194588B1 ES 2194588 B1 ES2194588 B1 ES 2194588B1 ES 200101648 A ES200101648 A ES 200101648A ES 200101648 A ES200101648 A ES 200101648A ES 2194588 B1 ES2194588 B1 ES 2194588B1
Authority
ES
Spain
Prior art keywords
precursors
optically pure
paroxetine
pure paroxetine
hydroxymethylpiperidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200101648A
Other languages
English (en)
Other versions
ES2194588A1 (es
Inventor
Miguel Bayod Jasanada
Victor M. Sanchez Pedregal
Vicente Gotor Santamaria
M. Rosario Brieva Collado
Gonzalo de Gonzalo Calvo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AsturPharma SA
Universidad de Oviedo
Original Assignee
AsturPharma SA
Universidad de Oviedo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AsturPharma SA, Universidad de Oviedo filed Critical AsturPharma SA
Priority to ES200101648A priority Critical patent/ES2194588B1/es
Priority to US10/192,768 priority patent/US20030018048A1/en
Priority to EP02380156A priority patent/EP1283200A3/en
Publication of ES2194588A1 publication Critical patent/ES2194588A1/es
Application granted granted Critical
Publication of ES2194588B1 publication Critical patent/ES2194588B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Procedimiento biocatalítico de obtención de derivados ópticamente enriquecidos de trans-4-(4-fluorofenil)-3-hidroximetilpiperidinas basado en la resolución enzimática de precursores racémicos de fórmula III (donde R3 es preferentemente fenilo o bencilo) mediante acilación del hidroxilo. Dependiendo de la enzima y de las condiciones de reacción, se puede obtener cualquiera de los dos enantiómeros con alta pureza enantiomérica. Estos compuestos son importantes intermedios en la síntesis del antidepresivo paroxetina.
ES200101648A 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina. Expired - Fee Related ES2194588B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES200101648A ES2194588B1 (es) 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina.
US10/192,768 US20030018048A1 (en) 2001-07-13 2002-07-10 Optically pure paroxetine precursors
EP02380156A EP1283200A3 (en) 2001-07-13 2002-07-10 Optically pure paroxetine precursors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200101648A ES2194588B1 (es) 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina.

Publications (2)

Publication Number Publication Date
ES2194588A1 ES2194588A1 (es) 2003-11-16
ES2194588B1 true ES2194588B1 (es) 2004-10-16

Family

ID=8498396

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200101648A Expired - Fee Related ES2194588B1 (es) 2001-07-13 2001-07-13 Precursores opticamente puros de paroxetina.

Country Status (3)

Country Link
US (1) US20030018048A1 (es)
EP (1) EP1283200A3 (es)
ES (1) ES2194588B1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2211327B1 (es) * 2002-12-18 2005-10-16 Astur Pharma S.A. Precursores opticamente puros de paroxetina.
ES2228274B1 (es) * 2003-09-24 2006-06-01 Astur Pharma, S.A. Sintesis quimioenzimatica de (+)-citalopram y (-)-citalopram.
EP2550873A1 (en) 2011-07-29 2013-01-30 AMBIENTE E NUTRIZIONE S.r.l. Process for the deep-freezing of a fluid food preparation
BR112019016775A2 (pt) 2017-02-17 2020-03-31 Trevena, Inc. Compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 7 membros, métodos de uso e produção dos mesmos
WO2023070605A1 (en) * 2021-10-29 2023-05-04 Trevena, Inc. Methods of preparing 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2104306C1 (ru) * 1989-11-13 1998-02-10 Пфайзер Инк. Способ получения оптически активного (2s)- или (2r)-эндо-бицикло[2.2.1]гептан-2-ола, способ получения 5-(3-[(2r)-экзо-бицикло[2.2.1]гепт-2-илокси]-4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-она, оптически активный 5-(3-[экзо-бицикло[2.2.1]гепт-2-илокси]4-метоксифенил)-3,4,5,6-тетрагидропиримидин-2(1н)-он, оптически активные промежуточные соединения и способ их получения
EP1394160A1 (en) * 1996-06-13 2004-03-03 SUMIKA FINE CHEMICALS Co., Ltd. Process for preparing crystalline paroxetin hydrochloride
JP2002526528A (ja) * 1998-10-07 2002-08-20 ジョージタウン ユニヴァーシティー 単量体およびニ量体の複素環、ならびにその治療的使用

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BASE DE DATOS CA en STN, AN 135:180691 & A. GOSWAMI et al. Organic Process Research and Development, Vol. 5, páginas 415-420, 2001, "Chemical and enzymatic resolution of (R,S)-N-(t-butoxycarbonyl)-3-hydroxymethylpiperidine". Resumen. *

Also Published As

Publication number Publication date
EP1283200A3 (en) 2003-03-05
ES2194588A1 (es) 2003-11-16
US20030018048A1 (en) 2003-01-23
EP1283200A2 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
FI92397B (fi) Menetelmä valmistaa farmaseuttisesti käyttökelpoisia indolijohdoksia
HUP0203186A2 (hu) Intermedierek rezolválása lényegében tiszta bicamlutamid szintézisében
DE69928821D1 (de) Auflösung von trans-2 (alkoxycarbonylethyl)-lactamen, nützlich bei der synthese von 1-(4-fluorophenyl)-3(r)-3(s)-hydroxy-3-(4-fluorophenyl)propyl]-4(s)-(4-hydroxyphenyl)-2-azetidinone
CY1108866T1 (el) Βελτιωμενη μεθοδος για την παρασκευη ενωσεων 3-υδροξυ-4-υδροξυμεθυλ-πυρρολιδινης
DE60001657D1 (de) Verfahren zur herstellung von n-(4-cyan-3-trifluormethylphenyl)-3-(4-flurophenylsulfonyl)-2-hydroxy-2-methylpropionamid
BR0317005A (pt) Processo para a preparação de compostos ativos opticamente puros
BR0313114A (pt) Método para a preparação de enanciÈmero s ou r de um diol, enanciÈmero s ou r de um composto, métodos para o isolamento e para a purificação de um composto e de um derivado acila, processo para a preparação de escitalopram, e, método para a preparação de citalopram e/ou escitalopram racêmicos ou de um sal farmaceuticamente aceitável dos mesmos
ES2194588B1 (es) Precursores opticamente puros de paroxetina.
CY1106454T1 (el) Μεθοδος για την παρασκευη των εναντιομepων μορφων των παραγωγων 1,3-κυκλοεξανοδιολης cis-διαταξης
ATE288891T1 (de) Verfahren zur herstellung von amid-derivaten und ihren zwischenverbindungen
HUP0003857A2 (hu) Eljárás alkoxi-furanon-amin-származékok előállítására, az eljárással kapott vegyületek és a vegyületek alkalmazása
NO985685L (no) Dibenzo-oksazepin- og -dioksazepin-derivater og deres anvendelse som anti-tumormidler
MXPA04003086A (es) Proceso para sintesis estereoselectiva de 2-hidroximetil-cromanos.
JO2498B1 (en) Methods of preparation of derivatives (3-oxy-33,2-2-dihydro-1-isoindol-1-yl)
PT1141374E (pt) Processo para a producao de derivados de 1-amino-4-(hidroximetil)ciclopent-2-eno opticamente activos
DK0492350T3 (da) Fremgangsmåde til fremstilling af (S)-vinyl- og (S)-allenyl-GABA
HUP9803034A2 (hu) Eljárás 1-(aminometil)-ciklohexán ecetsav előállítására és új köztitermékek
IT1188641B (it) Processo per la risoluzione enzimatica di 2-ammino-1-alcanoli racemi
JPH05227991A (ja) 光学活性な３−ピロリジノール誘導体の製造法
ES2211327B1 (es) Precursores opticamente puros de paroxetina.
DE602004014739D1 (de) Chemoenzymatisches verfahren zur stereoselektiven herstellung von optisch-angereicherten phenylglycidate
ES2134280T3 (es) Procedimiento de produccion de pilocarpina.
DE50204211D1 (de) Verfahren zur enzymatischen Herstellung von enantiomerenreinen 1,3-Dioxolan-4-on- und 1,3-Oxathiolan-5-on-Derivaten
DE60035194D1 (de) Verfahren zur herstellung von indol-derivaten und intermediaten dafür
DK1504021T3 (da) Fremgangsmåde til dehydrogenering af azaandrostanforbindelser

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20031116

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2194588B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20180807